Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-5b777bbd6c-4n89n Total loading time: 0 Render date: 2025-06-23T19:04:59.489Z Has data issue: false hasContentIssue false

Chapter 11 - Cannabinoids and the Skin

from Section 2 - Potential Therapeutic Uses of Cannabinoids in Clinical Practice

Published online by Cambridge University Press:  12 October 2020

Steven James
Steven James
Affiliation:
University of California, San Diego
Get access

Summary

In this chapter we will review selected preclinical and clinical studies for potential future development of cannabinoids in the treatment of skin diseases. Already there is a great deal of interest not only for the physiological and pharmacological properties of cannabinoids but also the potential benefits of formulations that could be provided as topical. However, this enthusiasm has not yet been matched by any regulatory agency globally and there are no approved indications from the US Food and Drug Administration (FDA), Canada Health and the European Medicines Agency (EMA) on the use of any cannabinoid in dermatology.

Type
Chapter
Information
A Clinician's Guide to Cannabinoid Science , pp. 137 - 148
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Ali, A. and Akhtar, N. (2015) ‘The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content’, Pakistan Journal of Pharmaceutical Sciences, 28(4), 1389–1395.Google ScholarPubMed
Ambrożewicz, E. et al. (2018) ‘Pathophysiological alterations of redox signaling and endocannabinoid system in granulocytes and plasma of psoriatic patients’, Cells, 7(10), 159. doi:10.3390/cells7100159.CrossRefGoogle ScholarPubMed
Appendino, G. et al. (2008) ‘Antibacterial cannabinoids from Cannabis sativa: a structure-activity study’, Journal of Natural Products, 71(8), 1427–1430. doi:10.1021/np8002673.Google Scholar
Bíró, T. et al. (2009) ‘Novel perspectives and therapeutic opportunities’, Trends in Pharmacological Sciences, 30(8), 411–420. doi:10.1016/j.tips.2009.05.004.The.CrossRefGoogle ScholarPubMed
Brunner, T. F. (1977) ‘Marijuana in ancient Greece and Rome? The literary evidence’, Journal of Psychoactive Drugs, 9(3), 221–225. doi:10.1080/02791072.1977.10472052.Google Scholar
Callaway, J. et al. (2005) ‘Efficacy of dietary hempseed oil in patients with atopic dermatitis’, Journal of Dermatological Treatment, 16(2), 87–94. doi:10.1080/09546630510035832.CrossRefGoogle ScholarPubMed
Clark, R. A. F., Nicol, N. and Adinoff, A. D. (1990) ‘Atopic dermatitis’, in Sams, W. M. and Lynch, P. J. (eds.), Principles and Practice of Dermatology. New York: Churchill Livingstone. pp. 365–380.Google Scholar
De Petrocellis, L. et al. (2012) ‘Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation’, Acta Physiologica, 204(2), 255–266. doi:10.1111/j.1748-1716.2011.02338.x.CrossRefGoogle ScholarPubMed
Del Río, C. et al. (2018) ‘The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders’, Biochemical Pharmacology, 122–133. doi:10.1016/j.bcp.2018.08.022.CrossRefGoogle Scholar
Gaffal, E. et al. (2013) ‘Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation’, The Journal of Immunology, 190(10), 4929–4936. doi:10.4049/jimmunol.1201777.CrossRefGoogle ScholarPubMed
Karsak, M. et al. (2007) ‘Attenuation of allergic contact dermatitis through the endocannabinoid system’, Science, 316(5830), 1494–1497. doi:10.1126/science.1142265.Google Scholar
Klein, T. W. and Cabral, G. A. (2006) ‘Cannabinoid-induced immune suppression and modulation of antigen-presenting cells’, Journal of Neuroimmune Pharmacology, 1(1), 50–64. doi:10.1007/s11481-005-9007-x.CrossRefGoogle ScholarPubMed
Krueger, J. G. and Bowcock, A. (2005) ‘Psoriasis pathophysiology: current concepts of pathogenesis’, Annals of the Rheumatic Diseases, 64(Suppl 2), ii30–ii36. doi:10.1136/ard.2004.031120.CrossRefGoogle ScholarPubMed
Lavery, M. J. et al. (2016) ‘Pruritus: an overview. What drives people to scratch an itch?’, Ulster Medical Journal, 85(3), 167–173.Google ScholarPubMed
Maccarrone, M. et al. (2003) ‘The endocannabinoid system in human keratinocytes: evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase’, Journal of Biological Chemistry, 278(36), 33896–33903.CrossRefGoogle ScholarPubMed
Martini, M. C. and Marks, J. G. (1990) ‘Contact dermatitis and contact urticaria’, in Sams, W. M. and Lynch, P. J. (eds.), Principles and Practice of Dermatology. New York: Churchill Livingstone. pp. 389–402.Google Scholar
Norooznezhad, A. H. and Norooznezhad, F. (2017) ‘Cannabinoids: possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation’, Medical Hypotheses, 99, 15–18. doi:10.1016/j.mehy.2016.12.003.CrossRefGoogle ScholarPubMed
Ogawa, E. et al. (2018) ‘Pathogenesis of psoriasis and development of treatment’, The Journal of Dermatology, 45(3), 264–272. doi:10.1111/1346-8138.14139.CrossRefGoogle ScholarPubMed
Pappas, A. et al. (2009) ‘Sebum analysis of individuals with and without acne’, Dermato-Endocrinology, 1(3), 157–161. doi:10.4161/derm.1.3.8473.Google Scholar
Ramot, Y. et al. (2013) ‘A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ’, PeerJ, 1, e40. doi:10.7717/peerj.40.CrossRefGoogle ScholarPubMed
Ryberg, E. et al. (2009) ‘The orphan receptor GPR55 is a novel cannabinoid receptor’, British Journal of Pharmacology, 152(7), 1092–1101. doi:10.1038/sj.bjp.0707460.Google Scholar
Sams, W. M. (1990) ‘Structure and function of skin’, in Sams, W. M. and Lynch, P. J. (eds.), Principles and Practice of Dermatology. New York: Churchill Livingstone. pp. 3–14.Google Scholar
Scheau, C. et al. (2020) ‘Cannabinoids in the pathophysiology of skin inflammation’, Molecules, 25(3), 652. doi:10.3390/molecules25030652.CrossRefGoogle ScholarPubMed
Shi, V. Y. et al. (2015) ‘Role of sebaceous glands in inflammatory dermatoses’, Journal of the American Academy of Dermatology, 73(5), 856–863. doi:10.1016/j.jaad.2015.08.015.Google Scholar
Ständer, S., Reinhardt, H. W. and Luger, T. A. (2006) ‘Topische cannabinoidagonisten. Eine effektive, neue möglichkeit zur behandlung von chronischem pruritus’, Der Hautarzt, 57(9), 801–807. doi:10.1007/s00105-006-1180-1.Google Scholar
Szántó, M. et al. (2019) ‘Activation of TRPV3 inhibits lipogenesis and stimulates production of inflammatory mediators in human sebocytes—a putative contributor to dry skin dermatoses’, Journal of Investigative Dermatology, 139(1), 250–253. doi:10.1016/j.jid.2018.07.015.CrossRefGoogle ScholarPubMed
Szepietowski, J. C., Szepietowski, T. and Reich, A. (2005) ‘Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study’, Acta Dermatovenerologica Croatica, 13(2), 97–103.Google Scholar
Telek, A. et al. (2007) ‘Inhibition of human hair follicle growth by endo- and exocannabinoids’, FASEB Journal, 21(13), 3534–3541. doi:10.1096/fj.06-7689com.CrossRefGoogle ScholarPubMed
Tóth, K. F. et al. (2019) ‘Cannabinoid signaling in the skin: therapeutic potential of the “c(ut)annabinoid” system’, Molecules, 24(5), 1–56. doi:10.3390/molecules24050918.Google Scholar
White, P. A. (1990) ‘Eczematous reaction patterns’, in Sams, W. M. and Lynch, P. J. (eds.), Principles and Practice of Dermatology. New York: Churchill Livingstone. pp. 381–388.Google Scholar
Wilkinson, J. D. and Williamson, E. M. (2007) ‘Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis’, Journal of Dermatological Science, 45(2), 87–92. doi:10.1016/j.jdermsci.2006.10.009.CrossRefGoogle ScholarPubMed
Yosipovitch, G., Rosen, J. D. and Hashimoto, T. (2018) ‘Itch: From mechanism to (novel) therapeutic approaches’, Journal of Allergy and Clinical Immunology, 142(5), 1375–1390. doi:10.1016/j.jaci.2018.09.005.Google Scholar
Zanolli, M. D. (1990) ‘Psoriasis and Reiter’s disease’, in Sams, W. M. and Lynch, P. J. (eds.), Principles and Practice of Dermatology. New York: Churchill Livingstone. pp. 307–324.Google Scholar
Zygmunt, P. M. et al. (1999) ‘Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide’, Nature, 74(9), 452–457. doi:10.1038/22761.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Cannabinoids and the Skin
  • Steven James, University of California, San Diego
  • Book: A Clinician's Guide to Cannabinoid Science
  • Online publication: 12 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781108583336.012
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Cannabinoids and the Skin
  • Steven James, University of California, San Diego
  • Book: A Clinician's Guide to Cannabinoid Science
  • Online publication: 12 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781108583336.012
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Cannabinoids and the Skin
  • Steven James, University of California, San Diego
  • Book: A Clinician's Guide to Cannabinoid Science
  • Online publication: 12 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781108583336.012
Available formats
×